68 Biggest Movers From Wednesday

Gainers

  • AeroClean Technologies, Inc. AERC shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
  • Longeveron Inc. LGVN rose 145.6% to settle at $42.30 on Wednesday after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Biofrontera Inc. BFRI shares climbed 98.5% to close $5.22 on Wednesday after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
  • IM Cannabis Corp. IMCC gained 37.8% to settle at $4.30. IM Cannabis recently announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
  • Local Bounti Corporation LOCL surged 32.6% to close at $10.62.
  • Blue Star Foods Corp. BSFC gained 29.9% to settle at $3.65. Blue Star Foods recently reported $3.73 million in quarterly sales.
  • Spark Networks SE LOV jumped 23.6% to close at $3.30. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
  • Femasys Inc. FEMY gained 22.9% to settle at $4.99. Femasys recently posted Q3 loss of $0.19 per share.
  • Standard Lithium Ltd. SLI surged 22.2% to close at $10.63 after the company announced a $100 million direct investment from Koch Strategic Platforms.
  • Cyclerion Therapeutics, Inc. CYCN gained 22.1% to settle at $2.65.
  • Trio-Tech International TRT jumped 21.5% to close at $10.75.
  • Trio-Tech recently reported Q1 results, posting a 49% year-over-year increase in total revenue.
  • Grom Social Enterprises, Inc. GROM rose 20.9% to close at $2.72. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
  • Dermata Therapeutics, Inc. DRMA gained 20.6% to settle at $2.81. Dermata Therapeutics recently announced data from its Phase 1b proof of concept study evaluating a single treatment of DMT410 to treat multiple aesthetic skin conditions.
  • Engine Gaming and Media, Inc. GAME rose 19.8% to close at $3.81 after the company reported Q4 2021 and FY21 revenue was higher year over year.
  • IDW Media Holdings, Inc. IDW gained 19.3% to close at $2.60.
  • Better Therapeutics, Inc. BTTX shares rose 19.1% to close at $7.68 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
  • Augmedix, Inc. AUGX gained 19% to settle at $3.45. Augmedix recently posted a Q3 net loss of $2.859 million.
  • Ocuphire Pharma, Inc. OCUP gained 18.8% to close at $4.1350 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
  • Society Pass Incorporated SOPA jumped 17.8% to settle at $13.17 amid continued volatility following the stock's IPO earlier in the month.
  • ForgeRock, Inc. FORG gained 17.6% to close at $29.14. The company recently posted upbeat quarterly results.
  • MyMD Pharmaceuticals, Inc. MYMD gained 17.2% to close at $7.10. MyMD Pharma Form 4 filing showed the company’s VP of Operations Paul Rivard bought 15,000 shares of co. stock on Nov. 23.
  • Nxt-ID, Inc. NXTD gained 17% to close at $3.10.
  • Rani Therapeutics Holdings, Inc. RANI jumped 16.9% to settle at $31.50.
  • Finch Therapeutics Group, Inc. FNCH gained 16.3% to close at $15.74. Finch Therapeutics Group recently announced positive topline results from PRISM-EXT, an open-label extension of the PRISM3 Phase 2 trial evaluating CP101 to prevent recurrent C. difficile infection (CDI).
  • Global-e Online Ltd. GLBE jumped 15.8% to close at $60.99 after the company announced it will acquire Flow Commerce for an aggregate purchase price of up to approximately $500 million.
  • Paltalk, Inc. PALT gained 15.7% to close at $4.06.
  • Recursion Pharmaceuticals, Inc. RXRX jumped 15.6% to close at $18.80.
  • Recursion Pharmaceuticals recently reported Q3 earnings results.
  • Brainstorm Cell Therapeutics Inc. BCLI gained 15.5% to close at $3.43. Brainstorm Cell recently posted Q3 loss of $0.15 per share.
  • Guardant Health, Inc. GH gained 15.5% to close at $107.25 following stock purchases by the company's Co-CEOs.
  • Instil Bio, Inc. TIL gained 14.5% to settle at $19.86
  • Golden Ocean Group Limited GOGL rose 14.1% to close at $9.12 after reporting Q3 results.
  • Foghorn Therapeutics Inc. FHTX gained 14.1% to close at $14.21. HC Wainwright & Co. recently initiated coverage on Foghorn Therapeutics with a Buy rating and announced a price target of $25.
  • Pure Storage, Inc. PSTG climbed 13.5% to settle at $30.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
  • Reviva Pharmaceuticals Holdings, Inc. RVPH gained 13.2% to close at $3.85. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
  • BIOLASE, Inc. BIOL rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
  • Guess', Inc. GES gained 11.4% to close at $23.73 after the company reported better-than-expected Q3 EPS and sales results and raised its quarterly dividend.
  • Benessere Capital Acquisition Corp. BENE climbed 10.4% to close at $11.23. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
  • Kidpik Corp. PIK gained 10.3% to close at $6.32. The company recently priced its IPO at $8.50 per share.
  • HP Inc. HPQ climbed 10.1% to settle at $35.44 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
  • Bridgeline Digital, Inc. BLIN rose 9.4% to close at $3.04.
  • Meiwu Technology Company Limited WNW shares rose 8.3% to close at $3.38.


Check out these big penny stock gainers and losers

Losers

  • Qualigen Therapeutics, Inc. QLGN shares fell 31.6% to settle at $1.75 on Wednesday after jumping around 105% on Tuesday.
  • Aptevo Therapeutics Inc. APVO fell 29.8% to close at $11.95. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
  • Nordstrom, Inc. JWN shares fell 29% to close at $22.66 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
  • Pasithea Therapeutics Corp. KTTA declined 28.8% to close at $3.99. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
  • Vallon Pharmaceuticals, Inc. VLON fell 26.2% to close at $5.39 on Wednesday after jumping over 80% on Tuesday.
  • The Gap, Inc. GPS fell 24.1% to close at $17.84 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
  • Esperion Therapeutics, Inc. ESPR shares fell 23.3% to close at $7.69 after surging over 40% on Tuesday.
  • iSpecimen Inc. ISPC fell 22.7% to close at $10.20. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Petros Pharmaceuticals, Inc. PTPI fell 21.8% to close at $1.83 after jumping over 75% on Tuesday.
  • Centogene N.V. CNTG fell 19.2% to close at $7.20. Centogene reported Q3 sales of €30.2 million, down 17% Y/Y, driven by decreasing revenues from COVID-19 testing.
  • MediciNova, Inc. MNOV shares fell 19.2% to close at $3.57 after surging 44% on Tuesday.
  • Outlook Therapeutics, Inc. OTLK fell 18.6% to close at $1.27 after the company reported a $10 million bought deal offering of common stock.
  • TDCX Inc. TDCX dropped 17.3% to close at $18.72 following Q3 results.
  • Nuvation Bio Inc. NUVB fell 16.2% to close at $7.75.
  • Kura Oncology, Inc. KURA declined 15.5% to close at $14.02 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
  • Autodesk, Inc. ADSK shares fell 15.5% to close at $256.90. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
  • Anaplan, Inc. PLAN shares fell 15.1% to close at $44.22 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
  • Viomi Technology Co., Ltd VIOT slipped 14% to close at $3.51 following Q3 results.
  • Eliem Therapeutics, Inc. ELYM declined 12.3% to settle at $15.48
  • Clarus Therapeutics Holdings, Inc. CRXT shares fell 12% to close at $5.05. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
  • Noah Holdings Limited NOAH dropped 11.4% to close at $39.03 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
  • NerdWallet, Inc. NRDS dropped 11.2% to close at $22.59. The company recently priced its IPO at $4 per share.
  • Gracell Biotechnologies Inc. GRCL fell 9% to close at $7.09. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
  • Titan Machinery Inc. TITN declined 8.8% to settle at $34.94. Baird downgraded Titan Machinery from Outperform to Neutral and raised the price target from $37 to $41.
  • Dillard's, Inc. DDS fell 7.9% to close at $377.67.
  • Citi Trends, Inc. CTRN declined 7.9% to settle at $84.01
  • Abercrombie & Fitch Co. ANF fell 4.6% to close at $39.25. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasInformation TechnologyInternet Software & ServicesMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!